Efficient inhibition of class A and class D β-lactamases by Michaelis complexes

被引:16
作者
Kalp, Matthew
Sheri, Anjaneyulu
Buynak, John D.
Bethel, Christopher R.
Bonomo, Robert A.
Carey, Paul R. [1 ]
机构
[1] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA
[4] Louis Stokes Cleveland Vet Affairs Med Ctr, Div Res, Cleveland, OH 44106 USA
[5] So Methodist Univ, Dept Chem, Dallas, TX 75275 USA
关键词
HETEROCYCLES; MECHANISM; CRYSTALS; BINDING;
D O I
10.1074/jbc.C700080200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A 6-alkylidiene penam sulfone, SA-1-204, is an efficient inhibitor of both SHV-1 and OXA-1 beta-lactamases with K-I = 42 +/- 4nM and 1.0 +/- 0.1 mu M, respectively. To gain insight into the reaction chemistry of SA-1-204, the reactions between this inhibitor and SHV-1 and OXA-1 were studied by Raman spectroscopy in single crystals and in solution. Raman signatures characteristic of the unreacted beta-lactam ring show that in both phases the inhibitor binds as a noncovalent Michaelis-like complex. This complex is present as the major population for periods of up to an hour. On longer time scales, the Raman data show that beta-lactam ring opening eventually leads to a complex mixture of reaction products. However, the data clearly demonstrate that the key species for inhibition on the time scale of bacterial half-lives is the noncovalent complex preceding acylation.
引用
收藏
页码:21588 / 21591
页数:4
相关论文
共 19 条
[1]   Comparing protein-ligand interactions in solution and single crystals by Raman spectroscopy [J].
Altose, MD ;
Zheng, YG ;
Dong, J ;
Palfey, BA ;
Carey, PR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) :3006-3011
[2]  
[Anonymous], GAUSSIAN 03
[3]   The synthesis and evaluation of 6-alkylidene-2′β-substituted penam sulfones as β-lactamase inhibitors [J].
Buynak, JD ;
Rao, AS ;
Doppalapudi, VR ;
Adam, G ;
Petersen, PJ ;
Nidamarthy, SD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (14) :1997-2002
[4]   The deacylation mechanism of AmpC β-lactamase at ultrahigh resolution [J].
Chen, Y ;
Minasov, G ;
Roth, TA ;
Prati, F ;
Shoichet, BK .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (09) :2970-2976
[5]   Inhibition of class C β-lactamases:: Structure of a reaction intermediate with a cephem sulfone [J].
Crichlow, GV ;
Nukaga, M ;
Doppalapudi, VR ;
Buynak, JD ;
Knox, JR .
BIOCHEMISTRY, 2001, 40 (21) :6233-6239
[6]   Probing inhibitors binding to human urokinase crystals by Raman microscopy: Implications for compound screening [J].
Dong, J ;
Swift, K ;
Matayoshi, E ;
Nienaber, VL ;
Weitzberg, M ;
Rockway, T ;
Carey, PR .
BIOCHEMISTRY, 2001, 40 (33) :9751-9757
[7]   Bacterial resistance to β-lactam antibiotics:: Compelling opportunism, compelling opportunity [J].
Fisher, JF ;
Meroueh, SO ;
Mobashery, S .
CHEMICAL REVIEWS, 2005, 105 (02) :395-424
[8]   Unexpected advanced generation cephalosporinase activity of the M69F variant of SHV β-lactamase [J].
Helfand, MS ;
Hujer, AM ;
Sönnichsen, FD ;
Bonomo, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (49) :47719-47723
[9]   Following the reactions of mechanism-based inhibitors with β-lactamase by Raman crystallography [J].
Helfand, MS ;
Totir, MA ;
Carey, MP ;
Hujer, AM ;
Bonomo, RA ;
Carey, PR .
BIOCHEMISTRY, 2003, 42 (46) :13386-13392
[10]   Structure of the SHV-1 β-lactamase [J].
Kuzin, AP ;
Nukaga, M ;
Nukaga, Y ;
Hujer, AM ;
Bonomo, RA ;
Knox, JR .
BIOCHEMISTRY, 1999, 38 (18) :5720-5727